Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial

Posted on by

Lancet Infectious Diseases
Sep 2021 Volume 21 Number 9 p1193-1332, e258-e301
https://www.thelancet.com/journals/laninf/issue/current

 

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial
Htay-Htay Han, et al.